Return to content in this issue

Use of Concentrated Plasma-Derived Subcutaneous C1 Inhibitor as Long-Term Prophylaxis in an 8-Year- Old Child With Hereditary Angioedema

Lasa EM¹, Herrero L², Martínez S¹, Arruti N¹, Oliver P², Joral A<sup>1

1</sup>Hospital Universitario de Donostia, San Sebastián, Spain
²Hospital de Mendaro, Mendaro, Spain

J Investig Allergol Clin Immunol 2023; Vol 33(4) : 302-304
doi: 10.18176/jiaci.0855

• Abstract
• Supplemental Materials

Key words: C1 inhibitor deficiency, Hereditary angioedema, Children, Long-term treatment, Management

	Title	Type	Size
	doi10.18176_jiaci.0855_supplemental-materials-tables_1.pdf	pdf	71.76 Kb